Trial Profile
Ticagrelor Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Percutaneous Coronary Intervention: The PL-PLATELET Randomized Trial
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms PL-PLATELET
- 25 Mar 2021 Status changed from recruiting to suspended, because competitive studies were conducted at the same time.
- 12 Sep 2017 Status changed from not yet recruiting to recruiting.
- 11 Jun 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jul 2017.